Clinical Trial Update: Nilotinib ± Peg-IFN for First Line Chronic Phase CML Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating nilotinib with or without pegylated interferon as first-line therapy for chronic-phase chronic myeloid leukemia has completed; the up…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Nilotinib (nilotinib)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Chronic Myeloid Leukemia | Phase 3 | Status: COMPLETED